Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Reflectance confocal microscopy reliably identifies skin cancer features like horizontal skin tissue sections.

Enzymes called PADIs play a key role in hair growth and loss.

Dermoscopy is useful for diagnosing different types of hair loss.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alternative treatments show promise for hair growth beyond traditional methods.

Researchers found that dissecting folliculitis of the scalp is linked to obesity, severity increases with duration and number of nodules, and early treatment is important to prevent scarring.

The combination therapy effectively improved acne keloidalis nuchae.

Hair thickness differences help diagnose hair loss severity.

Using a 308-nm excimer lamp with minoxidil promotes hair growth in Alopecia Areata patients, especially younger ones or those with smaller bald spots.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

New treatments targeting T-cell pathways are needed for better alopecia areata management.